Discover Pioneering Treatments for Illnesses
100 diseases · 11,280 research projects · 32,568 trial-treatment opportunities
- PatientsFind & apply for trial-stage treatments in your area
- DoctorsLatest news & treatments on illnesses
- ResearchersFind fellow researchers who work on the same disease
Choose one to continue
Our mission
Evidence-based portal on pioneering treatments.
Only research-based data. No myths, no miracle cures.
Every number comes from an official registry or a peer-reviewed publication — with the source and date shown.
- ClinicalTrials.gov (opens in a new tab)U.S. National Library of Medicine (NLM)Clinical trials registered worldwide
- PubMed (opens in a new tab)U.S. National Library of Medicine (NLM)Peer-reviewed medical publications
- EU CTIS (opens in a new tab)Clinical Trials Information System, European Medicines Agency (EMA)Clinical trials authorised in the EU
- OpenAlex (opens in a new tab)OurResearch (data released under CC0)Researchers, institutes and their work
Clinical trial and literature data courtesy of the U.S. National Library of Medicine (ClinicalTrials.gov, PubMed). EU clinical trial data: source European Medicines Agency, Clinical Trials Information System (CTIS). Scholarly metadata: OpenAlex (CC0), cited as Priem, J., Piwowar, H., & Orr, R. (2022). OpenAlex: A fully-open index of scholarly works, authors, venues, institutions, and concepts. ArXiv. arxiv.org/abs/2205.01833 (opens in a new tab)
We translate, summarise and restructure the source records; we do not change their study data. Each trial record shows the date ClinicalTrials.gov or EU CTIS last updated it, and links to the original, which is always the current official version.
Frontlight Research is an independent service of New Horizon Platforms Kft. It is not affiliated with, endorsed, sponsored or approved by the U.S. National Library of Medicine, the National Institutes of Health, the U.S. Department of Health and Human Services, the European Union, the European Medicines Agency or OurResearch. We name these sources only to show where our data come from.
Choose one to continue
Browse by disease
- Alzheimer disease15,581 new publications15,599 research teams work on this diseaseUpcoming new treatmentsPhase 3KarXTPhase 218F-MK6240Phase 1Florbetaben F 18906 open research and trial-treatment opportunities
- Lung cancer21,254 new publications18,106 research teams work on this diseaseUpcoming new treatmentsPhase 3CarboplatinPhase 2CarboplatinPhase 1Pembrolizumab3,148 open research and trial-treatment opportunities
- Pancreatic cancer7,499 new publications9,790 research teams work on this diseaseUpcoming new treatmentsPhase 3GemcitabinePhase 2GemcitabinePhase 1Pembrolizumab1,218 open research and trial-treatment opportunities
- Metastatic breast cancer3,793 new publications7,948 research teams work on this diseaseUpcoming new treatmentsPhase 3CapecitabinePhase 2FulvestrantPhase 1Fulvestrant729 open research and trial-treatment opportunities
- Colorectal cancer19,380 new publications14,795 research teams work on this diseaseUpcoming new treatmentsPhase 3BevacizumabPhase 2BevacizumabPhase 1Bevacizumab2,188 open research and trial-treatment opportunities
- Liver and biliary tract cancer16,127 new publications708 research teams work on this diseaseUpcoming new treatmentsPhase 3BevacizumabPhase 2LenvatinibPhase 1Durvalumab1,507 open research and trial-treatment opportunities
- Parkinson disease8,480 new publications13,023 research teams work on this diseaseUpcoming new treatmentsPhase 3Levodopa CarbidopaPhase 2Human Dopaminergic Progenitor CellsPhase 1Amyloid PET951 open research and trial-treatment opportunities
- Long COVID and ME/CFS2,515 new publications2,840 research teams work on this diseaseUpcoming new treatmentsPhase 3Active Smell Training (ST)Phase 2accelerated intermittent theta burst stimulationPhase 111C-PS13192 open research and trial-treatment opportunities
- Gastric and esophageal cancer10,427 new publications9,484 research teams work on this diseaseUpcoming new treatmentsPhase 3OxaliplatinPhase 2OxaliplatinPhase 1Pembrolizumab1,472 open research and trial-treatment opportunities
- Multiple myeloma3,141 new publications7,137 research teams work on this diseaseUpcoming new treatmentsPhase 3DexamethasonePhase 2DexamethasonePhase 1Dexamethasone780 open research and trial-treatment opportunities
- Glioblastoma5,206 new publications8,230 research teams work on this diseaseUpcoming new treatmentsPhase 3TemozolomidePhase 2TemozolomidePhase 1Temozolomide459 open research and trial-treatment opportunities
- Ovarian cancer5,522 new publications10,077 research teams work on this diseaseUpcoming new treatmentsPhase 3BevacizumabPhase 2BevacizumabPhase 1Bevacizumab887 open research and trial-treatment opportunities
- Acute myeloid leukemia4,355 new publications7,156 research teams work on this diseaseUpcoming new treatmentsPhase 3VenetoclaxPhase 2VenetoclaxPhase 1Venetoclax835 open research and trial-treatment opportunities
- Multiple sclerosis5,637 new publications9,555 research teams work on this diseaseUpcoming new treatmentsPhase 3FingolimodPhase 2Clemastine FumaratePhase 1CD20/BCMA-directed CAR-T cells619 open research and trial-treatment opportunities
- Childhood cancers8,796 new publications5,947 research teams work on this diseaseUpcoming new treatmentsPhase 3Biospecimen CollectionPhase 2CyclophosphamidePhase 1Cyclophosphamide2,715 open research and trial-treatment opportunities
- Prostate cancer11,535 new publications12,657 research teams work on this diseaseUpcoming new treatmentsPhase 3DocetaxelPhase 2EnzalutamidePhase 1Computed Tomography1,590 open research and trial-treatment opportunities
- Melanoma7,052 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3NivolumabPhase 2NivolumabPhase 1Nivolumab619 open research and trial-treatment opportunities
- Bladder cancer4,684 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3GemcitabinePhase 2PembrolizumabPhase 1Pembrolizumab688 open research and trial-treatment opportunities
- Kidney cancer4,077 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CabozantinibPhase 2NivolumabPhase 1Nivolumab524 open research and trial-treatment opportunities
- Head and neck cancer8,079 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CisplatinPhase 2CisplatinPhase 1Pembrolizumab1,019 open research and trial-treatment opportunities
- Thyroid cancer5,912 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CabozantinibPhase 2Biospecimen CollectionPhase 1Magnetic Resonance Imaging266 open research and trial-treatment opportunities
- Cervical cancer5,150 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CisplatinPhase 2CisplatinPhase 1Pembrolizumab615 open research and trial-treatment opportunities
- Endometrial cancer2,410 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3PaclitaxelPhase 2CarboplatinPhase 1Paclitaxel436 open research and trial-treatment opportunities
- Triple-negative breast cancer3,409 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3PembrolizumabPhase 2PembrolizumabPhase 1Pembrolizumab479 open research and trial-treatment opportunities
- Diffuse large B-cell lymphoma1,619 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3RituximabPhase 2CyclophosphamidePhase 1Biospecimen Collection379 open research and trial-treatment opportunities
- Hodgkin lymphoma1,036 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3BleomycinPhase 2CyclophosphamidePhase 1Biospecimen Collection159 open research and trial-treatment opportunities
- Follicular lymphoma365 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3RituximabPhase 2CyclophosphamidePhase 1Cyclophosphamide200 open research and trial-treatment opportunities
- Mantle cell lymphoma285 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3OrelabrutinibPhase 2ObinutuzumabPhase 1Cyclophosphamide158 open research and trial-treatment opportunities
- Chronic lymphocytic leukaemia927 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3VenetoclaxPhase 2Biospecimen CollectionPhase 1Biospecimen Collection328 open research and trial-treatment opportunities
- Acute lymphoblastic leukaemia2,128 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3BlinatumomabPhase 2CyclophosphamidePhase 1Cyclophosphamide617 open research and trial-treatment opportunities
- Chronic myeloid leukaemia894 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AzacitidinePhase 2Biospecimen CollectionPhase 1Biospecimen Collection192 open research and trial-treatment opportunities
- Myelodysplastic syndromes899 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3VenetoclaxPhase 2Biospecimen CollectionPhase 1Biospecimen Collection397 open research and trial-treatment opportunities
- Myeloproliferative neoplasms884 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3RuxolitinibPhase 2Biospecimen CollectionPhase 1Ruxolitinib236 open research and trial-treatment opportunities
- Mesothelioma597 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Atezolizumab 1200 mg in 20 ML InjectionPhase 2CarboplatinPhase 1Cisplatin111 open research and trial-treatment opportunities
- Sarcoma6,468 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Biospecimen CollectionPhase 2Biospecimen CollectionPhase 1Cyclophosphamide633 open research and trial-treatment opportunities
- Neuroendocrine tumours1,899 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3EverolimusPhase 2Biospecimen CollectionPhase 1Computed Tomography261 open research and trial-treatment opportunities
- Neuroblastoma1,615 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CarboplatinPhase 2TemozolomidePhase 1Cyclophosphamide132 open research and trial-treatment opportunities
- ALS (motor neurone disease)2,055 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Acetyl-l-carnitinePhase 2nL-CHCHD-001Phase 1LY4256984254 open research and trial-treatment opportunities
- Huntington's disease725 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3SKY-0515Phase 2High doses of Thiamine y BiotinPhase 1[14C] LPM377016452 open research and trial-treatment opportunities
- Epilepsy9,260 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3XEN1101Phase 2SPN-817Phase 1UX-GIP001506 open research and trial-treatment opportunities
- Migraine2,638 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3EptinezumabPhase 2Atorvastatin 40mgPhase 1Zavegepant297 open research and trial-treatment opportunities
- Stroke17,639 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Standard medical treatmentPhase 2LT3001 Drug:high dosePhase 1AB126 Neural Exosomes Intravenous Injection2,519 open research and trial-treatment opportunities
- Myasthenia gravis932 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3NipocalimabPhase 2Empasiprubart IVPhase 1Cyclophosphamide137 open research and trial-treatment opportunities
- Spinal muscular atrophy531 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3SalanersenPhase 2GC101Phase 1EXG001-307 injection72 open research and trial-treatment opportunities
- Frontotemporal dementia655 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3[18F]-PI-2620Phase 211C-ER176Phase 1[18F]ACI-19626116 open research and trial-treatment opportunities
- Lewy body dementia454 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3[123I]-MIBG SPECT CTPhase 218F-MFBGPhase 1[18F]ACI-1591687 open research and trial-treatment opportunities
- Neuromyelitis optica (NMOSD)523 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AzathioprinePhase 2Anti-BAFFR CARTPhase 1CD20/BCMA-directed CAR-T cells71 open research and trial-treatment opportunities
- CIDP (chronic inflammatory demyelinating polyneuropathy)183 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Empasiprubart IVPhase 2BAFF-R CARTPhase 1Cyclophosphamide50 open research and trial-treatment opportunities
- Depression4,656 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3NBI-1065845Phase 2PsilocybinPhase 1Ketamine745 open research and trial-treatment opportunities
- Schizophrenia5,600 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3KarXTPhase 2NMDAEPhase 1LY03017549 open research and trial-treatment opportunities
- Bipolar disorder2,308 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3KarXTPhase 2MelatoninPhase 1ABBV-932259 open research and trial-treatment opportunities
- Autism6,506 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3KarX-ECPhase 2Folinic AcidPhase 1Glutathione524 open research and trial-treatment opportunities
- Heart failure11,274 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3FinerenonePhase 2CDR132LPhase 1AD-118, AD-11811,410 open research and trial-treatment opportunities
- Atrial fibrillation6,529 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3ApixabanPhase 2ApixabanPhase 1[64Cu]FBP8836 open research and trial-treatment opportunities
- Coronary artery disease11,711 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3ClopidogrelPhase 2XC001Phase 1Brenzavvy (bexagliflozin), 20 mg Oral Tablet1,528 open research and trial-treatment opportunities
- High blood pressure11,463 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Treprostinil Palmitil Inhalation PowderPhase 2129Xe HyperpolarizedPhase 1BR1015-21,508 open research and trial-treatment opportunities
- Pulmonary arterial hypertension1,295 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Treprostinil Palmitil Inhalation PowderPhase 2129Xe HyperpolarizedPhase 118F-FGLN PET Imaging351 open research and trial-treatment opportunities
- Hypertrophic cardiomyopathy1,143 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Aficamten (5 - 20 mg)Phase 2Ademetionine 1,4-ButanedisulfonatePhase 1HTX-001103 open research and trial-treatment opportunities
- Amyloidosis1,707 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3BortezomibPhase 2DexamethasonePhase 1JNJ-79635322202 open research and trial-treatment opportunities
- Type 1 diabetes5,985 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3SemaglutidePhase 2SotagliflozinPhase 1Acetaminophen607 open research and trial-treatment opportunities
- Type 2 diabetes27,330 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3SemaglutidePhase 2SemaglutidePhase 1Empagliflozin 25 MG1,418 open research and trial-treatment opportunities
- Obesity25,699 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3TirzepatidePhase 2TirzepatidePhase 1Tirzepatide2,221 open research and trial-treatment opportunities
- Fatty liver disease (MASLD/MASH)7,794 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Efimosfermin alfaPhase 2ResmetiromPhase 1[6,6-2H2] D-glucose426 open research and trial-treatment opportunities
- Familial hypercholesterolaemia2,775 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3InclisiranPhase 22-HydroxybenzylaminePhase 1NGGT006135 open research and trial-treatment opportunities
- Osteoporosis6,410 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3alendronate sodiumPhase 2AbaloparatidePhase 1Blackcurrant (BC) extract190 open research and trial-treatment opportunities
- Chronic kidney disease12,685 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3DapagliflozinPhase 2SemaglutidePhase 1[14C]HRS-1780939 open research and trial-treatment opportunities
- IgA nephropathy813 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3PovetaciceptPhase 2SparsentanPhase 1UCAR T-cell105 open research and trial-treatment opportunities
- Polycystic kidney disease566 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3ControlPhase 2ABBV-CLS-628Phase 1JMKX003142 tablets54 open research and trial-treatment opportunities
- Crohn's disease4,194 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3GuselkumabPhase 2CyclophosphamidePhase 1[14C]ontunisertib467 open research and trial-treatment opportunities
- Ulcerative colitis5,427 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AfimkibartPhase 2MesalaminePhase 124mg bid TQH3906 capsule444 open research and trial-treatment opportunities
- Primary biliary cholangitis488 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3FenofibratePhase 2Cilofexor Dose APhase 1Saroglitazar Magnesium 1 mg45 open research and trial-treatment opportunities
- Asthma7,242 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3TezepelumabPhase 2KT-621Phase 1Adenosine 5'-triphosphate572 open research and trial-treatment opportunities
- COPD5,303 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3DepemokimabPhase 2HSK39004 Dry Powder Inhaler -0.75mg BIDPhase 1BBT002679 open research and trial-treatment opportunities
- Cystic fibrosis1,995 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3HSK31858, tabletPhase 24D-710Phase 1HSK31858 tablets200 open research and trial-treatment opportunities
- Idiopathic pulmonary fibrosis1,486 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3HSK44459Phase 2RituximabPhase 10.9% sodium chloride (normal saline)131 open research and trial-treatment opportunities
- Rheumatoid arthritis5,968 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3MethotrexatePhase 2MethotrexatePhase 1Cyclophosphamide429 open research and trial-treatment opportunities
- Lupus (SLE)3,611 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AnifrolumabPhase 2CyclophosphamidePhase 1Cyclophosphamide414 open research and trial-treatment opportunities
- Psoriasis3,962 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3ZasocitinibPhase 2BimekizumabPhase 1Methotrexate328 open research and trial-treatment opportunities
- Psoriatic arthritis761 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3ZasocitinibPhase 2RisankizumabPhase 1Apremilast IR138 open research and trial-treatment opportunities
- Ankylosing spondylitis949 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3608Phase 2608Phase 1Bimekizumab121 open research and trial-treatment opportunities
- Atopic dermatitis (eczema)3,083 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3VehiclePhase 2CM512Phase 1BBT001285 open research and trial-treatment opportunities
- Systemic sclerosis (scleroderma)1,250 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3BelimumabPhase 2CyclophosphamidePhase 1Cyclophosphamide246 open research and trial-treatment opportunities
- Sjögren's disease1,039 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3DazodalibepPhase 268Ga-FAPIPhase 1YTS109 cell92 open research and trial-treatment opportunities
- ANCA-associated vasculitis823 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AvacopanPhase 2RituximabPhase 1YTS109 cell103 open research and trial-treatment opportunities
- Duchenne muscular dystrophy727 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3GivinostatPhase 2ENTR-601-44Phase 1BBM-D101105 open research and trial-treatment opportunities
- Sickle cell disease1,638 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CTX001Phase 2AlemtuzumabPhase 1autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein219 open research and trial-treatment opportunities
- Haemophilia905 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3NXT007Phase 2ANB-002, dose 1Phase 1BBM-H901144 open research and trial-treatment opportunities
- Thalassaemia1,078 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3CTX001Phase 2AlemtuzumabPhase 1β-globin restored autologous hematopoietic stem cells90 open research and trial-treatment opportunities
- Fabry disease279 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3LucerastatPhase 24D-310Phase 1BBM-F101 injection50 open research and trial-treatment opportunities
- Gaucher disease156 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AZ-3102Phase 2AlemtuzumabPhase 1Aldurazyme (laronidase)35 open research and trial-treatment opportunities
- Pompe disease136 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Cipaglucosidase alfaPhase 2S-606001Phase 1Aldurazyme (laronidase)34 open research and trial-treatment opportunities
- Friedreich ataxia195 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3NomlabofuspPhase 2CTI-1601Phase 1AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN27 open research and trial-treatment opportunities
- Retinitis pigmentosa477 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 31.5 x 10^6 UC-MSC + CMPhase 2100 μg KIO-301Phase 1cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes77 open research and trial-treatment opportunities
- Macular degeneration1,881 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AfliberceptPhase 24D-150 IVTPhase 1HG202264 open research and trial-treatment opportunities
- Glaucoma3,086 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3Bimatoprost Implant SystemPhase 2NicotinamidePhase 1BIM-DRS High Dose271 open research and trial-treatment opportunities
- Diabetic eye disease2,747 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3AfliberceptPhase 2ACE RetinoPhase 1cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes174 open research and trial-treatment opportunities
- HIV12,644 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3BIC/FTC/TAFPhase 2Broadly neutralizing antibody (bNAb) ePGT121v1-LSPhase 1426c.Mod.Core-C4b901 open research and trial-treatment opportunities
- Hepatitis B2,753 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3GST-HG141Phase 2AHB-137Phase 1EPI-003241 open research and trial-treatment opportunities
- Tuberculosis8,416 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 3BedaquilinePhase 2IsoniazidPhase 1Rifampin233 open research and trial-treatment opportunities
- Endometriosis2,540 new publications200+ research teams work on this diseaseUpcoming new treatmentsPhase 340 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetatePhase 2[18F]AlF-FAPI-74 PET/CTPhase 1Enantone235 open research and trial-treatment opportunities